CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 4.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,520,884 | +24.2% | 1,693,736 | 0.0% | 1.35% | +19.3% |
| Q4 2022 | $5,250,582 | -22.9% | 1,693,736 | 0.0% | 1.13% | -28.8% |
| Q3 2022 | $6,809,000 | -17.4% | 1,693,736 | 0.0% | 1.59% | -27.8% |
| Q2 2022 | $8,248,000 | -51.2% | 1,693,736 | -10.1% | 2.20% | -48.3% |
| Q1 2022 | $16,900,000 | +2.8% | 1,884,096 | +29.1% | 4.26% | +33.4% |
| Q4 2021 | $16,436,000 | -36.0% | 1,459,693 | -5.1% | 3.19% | -20.8% |
| Q3 2021 | $25,677,000 | -24.8% | 1,537,533 | 0.0% | 4.03% | -4.4% |
| Q2 2021 | $34,149,000 | – | 1,537,533 | – | 4.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |